Adirondack Trust Company’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q4
Sell
-5
Closed -$5K 305
2013
Q3
$5K Hold
5
﹤0.01% 258
2013
Q2
$5K Buy
+5
New +$5K ﹤0.01% 265